newsfilter
← Latest News
PR Newswire·

Pulmatrix Announces Year-End and Fourth Quarter 2025 Financial Results

Pulmatrix, Inc. ("Pulmatrix" or the "Company") (Nasdaq: PULM), a biopharmaceutical company that has focused on the development of novel inhaled...